| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia
|
Diro, E.; Edwards, T.; Ritmeijer, K.; Fikre, H.; Abongomera, C.; Kibret, A.; Bardonneau, C.; Soipei, P.; Mutinda, B.; Omollo, R.; van Griensven, J.; Zijlstra, E. E.; Wasunna, M.; Alves, F.; Alvar, J.; Hailu, A.; Alexander, N.; Blesson, S.
|
PLoS Neglected Tropical Diseases |
2019
|
Article-E
|
|
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
|
Tedder, R. S.; Samuel, D.; Dicks, S.; Scott, J. T.; Ijaz, S.; Smith, C. C.; Adaken, C.; Cole, C.; Baker, S.; Edwards, T.; Kamara, P.; Kargbo, O.; Niazi, S.; Nwakanma, D.; D'Alessandro, U.; Burch, G.; Doughty, H.; Brown, C. S.; Andrews, N.; Glynn, J. R.; van Griensven, J.; Pollakis, G.; Paxton, W. A.; Semple, M. G.
|
Transfusion |
2018
|
Article
|
|
Evaluation of convalescent plasma for Ebola virus disease in Guinea
|
van Griensven, J.; Edwards, T.; de Lamballerie, J.; Semple, M. G.; Gallian, P.; Baize, S.; Horby, P. W.; Raoul, H.; Magassouba, N.; Antierens, A.; Lomas, C.; Faye, O.; Sall, A. A.; Fransen, K.; Buyze, J.; Ravinetto, R.; Tiberghien, P.; Claeys, Y.; De Crop, M.; Lynen, L.; Bah, E. I.; Smith, P. G.; Delamou, A.; De Weggheleire, A.; Haba, N.
|
New England Journal of Medicine |
2016
|
Article
|
|
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak
|
Edwards, T.; Semple, M. G.; De Weggheleire, A.; Claeys, Y.; De Crop, M.; Menten, J.; Ravinetto, R.; Temmerman, S.; Lynen, L.; Bah, E. I.; Smith, P. G.; van Griensven, J.
|
Clinical Trials |
2016
|
Article-E
|
|
The use of Ebola convalescent plasma to treat Ebola Virus Disease in resource constrained settings: A perspective from the field
|
van Griensven, J.; De Weggheleire, A.; Delamou, A.; Smith, P. G.; Edwards, T.; Vandekerckhove, P.; Ibrahima Bah, E.; Colebunders, R.; Herve, I.; Lazaygues, C.; Haba, N.; Lynen, L.
|
Clinical Infectious Diseases |
2016
|
Article
|
|
Convalescent plasma for Ebola virus disease [author's reply]
|
Van Griensven, J.; Edwards, T.; Gallian, P.
|
New England Journal of Medicine |
2016
|
Letter
|
|
Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies [correspondence]
|
Van Griensven, J.; Edwards, T.; Baize, S.
|
New England Journal of Medicine |
2016
|
Letter
|